Transglutaminase 2 inhibition found to induce p53 mediated apoptosis in renal cell carcinoma-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Transglutaminase 2 inhibition found to induce p53 mediated apoptosis in renal cell carcinoma

Published:2013-05-23 Issue:9 Volume:27 Page:3487-3495
ISSN:0892-6638
Container-title:The FASEB Journal
language:en
Short-container-title:FASEB j.

Author:

Ku Bo Mi¹,Kim Dae‐Seok¹,Kim Kyung‐Hee²,Yoo Byong Chul²,Kim Seok‐Hyun¹,Gong Young‐Dae³,Kim Soo‐Youl¹

Affiliation:

1. Cancer Cell and Molecular Biology BranchDivision of Cancer BiologyResearch InstituteNational Cancer CenterGoyangKorea

2. Colorectal Cancer BranchDivision of Translational and Clinical Research IResearch InstituteNational Cancer CenterGoyangKorea

3. Center for Innovative Drug Library ResearchDongguk UniversitySeoulKorea

Publisher

Wiley

Subject

Genetics,Molecular Biology,Biochemistry,Biotechnology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1096/fj.12-224220

Reference26 articles.

1. The Epidemiology of Renal Cell Carcinoma

2. Sunitinib versus Interferon Alfa in Metastatic Renal-Cell Carcinoma

3. Patterns of failure following surgical resection of renal cell carcinoma: implications for adjuvant local and systemic therapy.

4. Infrequent alteration of p53 pathway in metastatic renal cell carcinoma;Kawasaki T.;Oncol. Rep.,1999

5. Modes of p53 Regulation

Cited by 49 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Discovery of novel 1H-benzo[d]imidazole-4,7-dione based transglutaminase 2 inhibitors as p53 stabilizing anticancer agents in renal cell carcinoma;Bioorganic Chemistry;2024-02

2. Biochemical and Functional Characterization of the Three Zebrafish Transglutaminases 2;International Journal of Molecular Sciences;2023-07-27

3. Complete Models of p53 Better Inform the Impact of Hotspot Mutations;International Journal of Molecular Sciences;2022-12-03

4. TfR Aptamer Enhanced Blood‐Brain Barrier Penetration of Biomimetic Nanocomplexes for Intracellular Transglutaminase 2 Imaging and Silencing in Glioma;Small;2022-08-18

5. Kidney cancer biomarkers and targets for therapeutics: survivin (BIRC5), XIAP, MCL-1, HIF1α, HIF2α, NRF2, MDM2, MDM4, p53, KRAS and AKT in renal cell carcinoma;Journal of Experimental & Clinical Cancer Research;2021-08-12

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3